Attitudes and engagement about cascade genetic testing among women diagnosed with cancer.
Steven J. Katz(University of Michigan), Allison W. Kurian(Stanford University), Rachel Hodan(Cancer Institute (WIA)), Lauren P. Wallner(University of Michigan), Paul Abrahamse(University of Michigan), Sarah T. Hawley(VA Ann Arbor Healthcare System)
Cited by 1
Related Papers
A Structured Tumor-Immune Microenvironment in Triple Negative Breast Cancer Revealed by Multiplexed Ion Beam Imaging
|Cell|2018|1.2k
Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology
|Journal of the National Comprehensive Cancer Network|2021|1.1k
A Population-Based Study of Genes Previously Implicated in Breast Cancer
|New England Journal of Medicine|2021|862
NCCN Guidelines Insights: Genetic/Familial High-Risk Assessment: Breast and Ovarian, Version 2.2017
|Journal of the National Comprehensive Cancer Network|2016|660
Genetic/Familial High-Risk Assessment: Breast and Ovarian
|Journal of the National Comprehensive Cancer Network|2010|650